SCHEMBL23634879

SCHEMBL23634879

O=Cc1ccc2c(ccc3occ(C4CCC(=O)NC4=O)c32)c1

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 17/20 0.40
CRBN Q96SW2 17/20 0.40
CYP2A6 P11509 1/20 0.34
POLB P06746 1/20 0.34
PTPN1 P18031 1/20 0.34
IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23634876 0.91 DDB1 (0.39) DDB1CRBNIDO1
SCHEMBL29322392 0.85 CRBN (0.41) DDB1CRBNIDO1
SCHEMBL23634965 0.85 DDB1 (0.47) DDB1CRBNIDO1
SCHEMBL23634846 0.85 DDB1 (0.47) DDB1CRBNIDO1
SCHEMBL23634964 0.85 DDB1 (0.47) DDB1CRBNIDO1
SCHEMBL24950356 0.85 CRBN (0.46) DDB1CRBN
SCHEMBL31426098 0.84 CRBN (0.45) DDB1CRBNPOLB
SCHEMBL23634859 0.84 CRBN (0.41) DDB1CRBNPOLB
SCHEMBL23634982 0.84 CRBN (0.41) DDB1CRBNPOLB
SCHEMBL23634857 0.84 CRBN (0.41) DDB1CRBNPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3848363-B1 TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND MEDSHINE DISCOVERY INC (CN) 2023-07-19 EP disclosed
US-20210317109-A1 TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND MEDSHINE DISCOVERY INC. (CN) 2021-10-14 US disclosed
EP-3848363-A1 TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND Medshine Discovery Inc. (CN) 2021-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317109-A1 TRICYCLIC SUBSTITUTED PIPERIDINE DIONE COMPOUND CRBN, CLNS1A, ADRM1 DDB1 456/4885CRBN 1/4885CYP2A6 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.